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background:  The optimal treatment strategy for ST-segment elevation myocardial infarction (STEMI) patients with multi-vessel disease (MVD) 
remains controversial. We sought to clarify the relation between the strategies of percutaneous coronary intervention (PCI) in multivessel disease 
(staged multivessel PCI versus culprit-only PCI) and long-term mortality in patients with STEMI undergoing primary PCI.
methods:  The CREDO-Kyoto Acute Myocardial Infarction (AMI) registry enrolled consecutive AMI patients who underwent their coronary 
revascularization in 2005-2007. The current study population consisted of 3892 STEMI patients who underwent primary PCI in the CREDO-Kyoto AMI 
Registry. 
results:  During 5-year follow-up (median 1839±729 days), patients with MVD (N=2010) had a significantly higher cumulative incidence of all-
cause death compared with patients with single vessel disease (N=1882) (24.1% versus 16.1%, p<0.001). After excluding 555 MVD patients with 
non-culprit vessel PCI during the index PCI procedure, age of ≥90 years, Killip class ≥3, and coronary artery bypass graft surgery within 90 days after 
primary PCI, 735 MVD patients underwent staged PCI for non-culprit lesions within 90 days after primary PCI (staged PCI group), while 720 MVD 
patients received primary PCI for the culprit lesion only (culprit-only PCI group). A landmark analysis at 90-days showed that the cumulative 5-year 
incidence of and the adjusted risk for all-cause death were significantly higher in the culprit-only PCI group compared with the staged PCI group 
(16.2% versus 9.3%, p<0.001; hazard ratio 0.65, 95% confidence interval 0.46-0.93 p=0.019).
Conclusions:  In STEMI patients with MVD who underwent primary PCI, the staged PCI strategy for non-culprit lesions was associated with better 
5-year mortality compared with culprit-only PCI strategy.
